National Bank of Canada
NVAX icon

National Bank of Canada’s Novavax NVAX Stock Holding History

National Bank of Canada’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Buy
2,048
+1,194
+140% +$10.8K ﹤0.01% 2213
2025
Q4 		$5.73K Sell
854
-50,535
-98% -$381K ﹤0.01% 2412
2025
Q3 		$446K Sell
51,389
-25,835
-33% -$201K ﹤0.01% 1366
2025
Q2 		$486K Buy
+77,224
New +$511K ﹤0.01% 1412
2025
Q1 		– Sell
-18,234
Closed -$147K – 3060
2024
Q4 		$147K Buy
18,234
+17,296
+1,844% +$167K ﹤0.01% 1677
2024
Q3 		$11.8K Sell
938
-1,588
-63% -$20.5K ﹤0.01% 2050
2024
Q2 		$32.1K Sell
2,526
-385,518
-99% -$3.88M ﹤0.01% 1832
2024
Q1 		$3.45M Buy
388,044
+385,829
+17,419% +$1.79M 0.01% 901
2023
Q4 		$11.1K Sell
2,215
-62,343
-97% -$382K ﹤0.01% 2144
2023
Q3 		$458K Sell
64,558
-784,287
-92% -$6.27M ﹤0.01% 1360
2023
Q2 		$6.26M Buy
848,845
+505,970
+148% +$3.98M 0.01% 660
2023
Q1 		$2.38M Sell
342,875
-140,240
-29% -$1.29M 0.01% 808
2022
Q4 		$4.97M Buy
483,115
+481,780
+36,088% +$8.5M 0.01% 611
2022
Q3 		$24K Buy
1,335
+180
+16% +$7.8K ﹤0.01% 1968
2022
Q2 		$59K Sell
1,155
-2,136
-65% -$111K ﹤0.01% 1719
2022
Q1 		$242K Buy
3,291
+1,850
+128% +$165K ﹤0.01% 1463
2021
Q4 		$206K Buy
+1,441
New +$248K ﹤0.01% 1455

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's NVAX Position: Q1 2026 in Review

National Bank of Canada increased its Novavax (NVAX) stake by 140% in Q1 2026, buying an estimated $10.8K and bringing the position to 2,048 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.

National Bank of Canada first reported a position in NVAX in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.26M in Q2 2023. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • National Bank of Canada held 2,048 shares of Novavax worth $16.7K as of Q1 2026.
  • National Bank of Canada bought 1,194 Novavax shares in Q1 2026, an estimated $10.8K.
  • Novavax made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2213 holding.
  • National Bank of Canada first reported a position in Novavax in Q4 2021 and has held it in 17 quarters since.
  • National Bank of Canada's Novavax position peaked at $6.26M in Q2 2023.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.